2018
As a long-time partner to Indonesia’s TB screening efforts, researchers studied the use of CAD4TB among Indonesians living with Diabetes Mellitus (PLWD). This was particularly important as Diabetes Mellitus is a significant risk factor for TB.
The study, already published in 2018, showed the potential use of CAD4TB as a triage tool for TB screening in PLWD, significantly reducing the need for microbiological examination.
2025
A retrospective study of 1,100+ chest X-rays in an Indonesian hospital showed CAD4TB v7 achieved 81% sensitivity and 64% specificity, comparable to radiologists. Its accuracy remained strong among patients without pleural effusion or HIV, and those without prior TB. These results highlight CAD4TB’s value as a reliable triage tool, especially in complex cases and settings lacking immediate radiology expertise.
2026
A new study published in Frontiers in Digital Health evaluated CAD4TB in more than 3,200 chest X-rays from patients with suspected TB in Indonesia. The researchers found that CAD4TB achieved diagnostic performance comparable to expert radiologists while delivering higher specificity (71.4% vs. 57.6%) at the same sensitivity, supporting its use as a rapid and standardized screening tool in resource-limited settings.